Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

POWERPLAY: Promoting Men's Health at Work (POWERPLAY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03548077
Recruitment Status : Recruiting
First Posted : June 6, 2018
Last Update Posted : December 18, 2018
Sponsor:
Collaborators:
Athabasca University
Northern Health, British Columbia, Canada
British Columbia Cancer Agency
Canadian Cancer Society Research Institute (CCSRI)
Information provided by (Responsible Party):
Joan Bottorff, University of British Columbia

Brief Summary:
With funding from the Candian Cancer Society, the Men's Healthy Eating Active Living (MHEAL) project began the development, evaluation, and optimization of a program called POWERPLAY to promote men's health at work.

Condition or disease Intervention/treatment Phase
Men Health Behavior Health Knowledge, Attitudes, Practice Cancer Behavioral: POWERPLAY Not Applicable

Detailed Description:
The MHEAL project began November 2013 and a program (called "POWERPLAY") was developed to support men's active living and healthy eating based on a systematic review of the literature and consultations with groups of men. From 2014-2017 six male-dominated worksites in northern BC offered POWERPLAY and participated in this study. Using a quasi-experimental pre-post design as well as interviews with worksite leads, the program was demonstrated to be an effective, feasible, and acceptable approach to the promotion of modifiable behaviours known to reduce the risk of cancer among working men in northern settings, and several manuscripts were published. Furthermore, the POWERPLAY program was optimized based on feedback received to include friendly competitions, weekly motivational messages, men-friendly language/images, and pedometers, and a manual for employers and website were developed (http://www.powerplayatwork.com/). A new module to support mental well-being was created in 2017 based on a systematic review of the literature for men's mental wellness programs, consultations with men working in northern workplaces, and interviews with workplace representatives. A module to support smoking cessation module was created in 2018.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 250 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Quasi-experimental, pre-post study design
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Harmonization Project: Men's Healthy Eating Active Living (MHEAL)
Actual Study Start Date : September 24, 2014
Estimated Primary Completion Date : June 30, 2019
Estimated Study Completion Date : September 30, 2019

Arm Intervention/treatment
Experimental: Intervention group
Powerplay, a workplace wellness program designed for male-dominated work sites, is the intervention. The program focuses on physical activity, healthy eating, mental wellness, and smoking cessation as well as promoting changes in workplace environments to support employee health and wellness. Program delivery is supported with a detailed program manual and web-based resources. More information about the intervention is available here: http://www.powerplayatwork.com/
Behavioral: POWERPLAY
All men from participating worksites are invited to completed surveys prior to and following implementation of a workplace wellness program (called "POWERPLAY")




Primary Outcome Measures :
  1. Physical Activity [ Time Frame: 6 months ]
    Weekly physical activity was assessed using the Godin Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985).


Secondary Outcome Measures :
  1. Healthy Eating [ Time Frame: 6 months ]
    Self-reported servings of fruits and vegetables



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Participant eligibility based on self-representation of gender identity
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Men employed in participating workplaces, full-time or part-time, in any position within the organization

Exclusion Criteria:

Although females were not discouraged from participating in the POWERPLAY program, they were not included in the evaluation.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03548077


Contacts
Layout table for location contacts
Contact: Joan L Bottorff, PhD, RN 2504481830 joan.bottorff@ubc.ca

Locations
Layout table for location information
Canada, British Columbia
Faculty of Health and Social Development Recruiting
Kelowna, British Columbia, Canada, V1V 1V7
Contact: Joan Bottorff    2508078627    joan.bottorff@ubc.ca   
Sponsors and Collaborators
University of British Columbia
Athabasca University
Northern Health, British Columbia, Canada
British Columbia Cancer Agency
Canadian Cancer Society Research Institute (CCSRI)
Investigators
Layout table for investigator information
Principal Investigator: Joan L Bottorff, PhD, RN University of British Columbia

Additional Information:
Publications of Results:
Other Publications:
Layout table for additonal information
Responsible Party: Joan Bottorff, Professor, University of British Columbia
ClinicalTrials.gov Identifier: NCT03548077     History of Changes
Other Study ID Numbers: 702831
First Posted: June 6, 2018    Key Record Dates
Last Update Posted: December 18, 2018
Last Verified: December 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No